Tandem Diabetes Care (TNDM) Capital Expenditures (2013 - 2026)

Tandem Diabetes Care (TNDM) has 14 years of Capital Expenditures data on file, last reported at $6.3 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 111.4% year-over-year to $6.3 million; the trailing twelve-month figure through Mar 2026 stood at $23.3 million (up 2470.13% YoY), and the FY2025 full-year result was $19.9 million, up 3803.72% from the prior year.
• Capital Expenditures for Q1 2026 stood at $6.3 million, down from $19.1 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $19.1 million in Q4 2025 and bottomed at -$18.7 million in Q4 2023.
• The 5-year median for Capital Expenditures is $5.2 million (2024), against an average of $3.8 million.
• The widest annual swing landed in 2022, when Capital Expenditures surged 2680.93%; it then sank 431.6% in 2023.
• A 5-year view of Capital Expenditures shows it stood at $5.6 million in 2022, then tumbled by 431.6% to -$18.7 million in 2023, then climbed by 16.12% to -$15.7 million in 2024, then soared by 222.15% to $19.1 million in 2025, then tumbled by 67.21% to $6.3 million in 2026.
• The last three Capital Expenditures figures came in at $6.3 million (Q1 2026), $19.1 million (Q4 2025), and -$243000.0 (Q3 2025), per Business Quant data.

Peer Comparison